Exciting developments for new treatment research
In recent years there has, understandably, been a lot of excitement around cutting-edge therapies that target the specific genetic faults underlying inherited sight loss.
Search
Search results
Research brings hope for the future
“All the promising research makes you feel like there is light at the end of that very dark tunnel after all.”
Fundraising FAQs
Fancy fundraising for Retina UK? Here’s a few pointers to help get you started.
Positive early findings from ProQR trial of USH2A therapy
Biotechnology company ProQR has announced encouraging results from its early analysis of the phase 1/2 trial of QR-421a, an innovative approach to treating sight loss caused by mutations in a particular section of the USH2A gene.